Tomokazu Kawaoka

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study

Masatoshi Kudo, Zhenggang Ren, Yabing Guo et al. · The Lancet · 2025 · 251 citations

Medicine, Oncology, Pharmacotherapy +16

Circulating microRNA‐22 correlates with microRNA‐122 and represents viral replication and liver injury in patients with chronic hepatitis B

Keiko Arataki, C. Nelson Hayes, Sakura Akamatsu et al. · Journal of Medical Virology · 2013 · 72 citations

Medicine, Infectious Diseases, Molecular Biology +15

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis

Akira Hiramatsu, Hiroshi Aikata, Shinsuke Uchikawa et al. · Hepatology Communications · 2019 · 66 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Hepatitis B Virus-Specific miRNAs and Argonaute2 Play a Role in the Viral Life Cycle

C. Nelson Hayes, Sakura Akamatsu, Masataka Tsuge et al. · PLoS ONE · 2012 · 57 citations · Full text

Life Sciences, Biology, Molecular Biology +11

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

Yuko Nagaoki, Michio Imamura, Hiroshi Aikata et al. · PLoS ONE · 2017 · 57 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17